Global and Japan Measles Vaccine Market Insights, Forecast to 2027

Global and Japan Measles Vaccine Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Measles Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Measles Vaccine Market Size Growth Rate by Type
1.2.2 Mumps Measles Rubella Vaccine, Live (MMR-II)
1.2.3 Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
1.3 Market by Application
1.3.1 Global Measles Vaccine Market Size Growth Rate by Application
1.3.2 Children
1.3.3 Adults
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Measles Vaccine Market Size, Estimates and Forecasts
2.1.1 Global Measles Vaccine Revenue 2016-2027
2.1.2 Global Measles Vaccine Sales 2016-2027
2.2 Global Measles Vaccine, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Measles Vaccine Historical Market Size by Region (2016-2021)
2.3.1 Global Measles Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Measles Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Measles Vaccine Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Measles Vaccine Sales Forecast by Region (2022-2027)
2.4.2 Global Measles Vaccine Revenue Forecast by Region (2022-2027)
3 Global Measles Vaccine Competitor Landscape by Players
3.1 Global Top Measles Vaccine Manufacturers by Sales
3.1.1 Global Measles Vaccine Sales by Manufacturer (2016-2021)
3.1.2 Global Measles Vaccine Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Measles Vaccine Manufacturers by Revenue
3.2.1 Key Measles Vaccine Manufacturers Covered: Ranking by Revenue
3.2.2 Global Measles Vaccine Revenue by Manufacturers (2016-2021)
3.2.3 Global Measles Vaccine Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Measles Vaccine Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Measles Vaccine Revenue in 2020
3.2.6 Global Measles Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Measles Vaccine Price by Manufacturers
3.4 Global Measles Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Measles Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Measles Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Measles Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Measles Vaccine Market Size by Type (2016-2021)
4.1.1 Global Measles Vaccine Sales by Type (2016-2021)
4.1.2 Global Measles Vaccine Revenue by Type (2016-2021)
4.1.3 Measles Vaccine Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Measles Vaccine Market Size Forecast by Type (2022-2027)
4.2.1 Global Measles Vaccine Sales Forecast by Type (2022-2027)
4.2.2 Global Measles Vaccine Revenue Forecast by Type (2022-2027)
4.2.3 Measles Vaccine Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Measles Vaccine Market Size by Application (2016-2021)
5.1.1 Global Measles Vaccine Sales by Application (2016-2021)
5.1.2 Global Measles Vaccine Revenue by Application (2016-2021)
5.1.3 Measles Vaccine Price by Application (2016-2021)
5.2 Measles Vaccine Market Size Forecast by Application (2022-2027)
5.2.1 Global Measles Vaccine Sales Forecast by Application (2022-2027)
5.2.2 Global Measles Vaccine Revenue Forecast by Application (2022-2027)
5.2.3 Global Measles Vaccine Price Forecast by Application (2022-2027)
6 Japan by Players, Type and Application
6.1 Japan Measles Vaccine Market Size YoY Growth 2016-2027
6.1.1 Japan Measles Vaccine Sales YoY Growth 2016-2027
6.1.2 Japan Measles Vaccine Revenue YoY Growth 2016-2027
6.1.3 Japan Measles Vaccine Market Share in Global Market 2016-2027
6.2 Japan Measles Vaccine Market Size by Players (International and Local Players)
6.2.1 Japan Top Measles Vaccine Players by Sales (2016-2021)
6.2.2 Japan Top Measles Vaccine Players by Revenue (2016-2021)
6.3 Japan Measles Vaccine Historic Market Review by Type (2016-2021)
6.3.1 Japan Measles Vaccine Sales Market Share by Type (2016-2021)
6.3.2 Japan Measles Vaccine Revenue Market Share by Type (2016-2021)
6.3.3 Japan Measles Vaccine Price by Type (2016-2021)
6.4 Japan Measles Vaccine Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Measles Vaccine Sales Forecast by Type (2022-2027)
6.4.2 Japan Measles Vaccine Revenue Forecast by Type (2022-2027)
6.4.3 Japan Measles Vaccine Price Forecast by Type (2022-2027)
6.5 Japan Measles Vaccine Historic Market Review by Application (2016-2021)
6.5.1 Japan Measles Vaccine Sales Market Share by Application (2016-2021)
6.5.2 Japan Measles Vaccine Revenue Market Share by Application (2016-2021)
6.5.3 Japan Measles Vaccine Price by Application (2016-2021)
6.6 Japan Measles Vaccine Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Measles Vaccine Sales Forecast by Application (2022-2027)
6.6.2 Japan Measles Vaccine Revenue Forecast by Application (2022-2027)
6.6.3 Japan Measles Vaccine Price Forecast by Application (2022-2027)
7 North America
7.1 North America Measles Vaccine Market Size YoY Growth 2016-2027
7.2 North America Measles Vaccine Market Facts & Figures by Country
7.2.1 North America Measles Vaccine Sales by Country (2016-2021)
7.2.2 North America Measles Vaccine Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Measles Vaccine Market Size YoY Growth 2016-2027
8.2 Asia Pacific Measles Vaccine Market Facts & Figures by Region
8.2.1 Asia Pacific Measles Vaccine Sales by Region (2016-2021)
8.2.2 Asia Pacific Measles Vaccine Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Measles Vaccine Market Size YoY Growth 2016-2027
9.2 Europe Measles Vaccine Market Facts & Figures by Country
9.2.1 Europe Measles Vaccine Sales by Country (2016-2021)
9.2.2 Europe Measles Vaccine Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Measles Vaccine Market Size YoY Growth 2016-2027
10.2 Latin America Measles Vaccine Market Facts & Figures by Country
10.2.1 Latin America Measles Vaccine Sales by Country (2016-2021)
10.2.2 Latin America Measles Vaccine Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Measles Vaccine Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Measles Vaccine Market Facts & Figures by Country
11.2.1 Middle East and Africa Measles Vaccine Sales by Country (2016-2021)
11.2.2 Middle East and Africa Measles Vaccine Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 GSK
12.1.1 GSK Corporation Information
12.1.2 GSK Description and Business Overview
12.1.3 GSK Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 GSK Measles Vaccine Products Offered
12.1.5 GSK Recent Development
12.2 Sanofi-Pasteur
12.2.1 Sanofi-Pasteur Corporation Information
12.2.2 Sanofi-Pasteur Description and Business Overview
12.2.3 Sanofi-Pasteur Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Sanofi-Pasteur Measles Vaccine Products Offered
12.2.5 Sanofi-Pasteur Recent Development
12.3 Merck
12.3.1 Merck Corporation Information
12.3.2 Merck Description and Business Overview
12.3.3 Merck Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Merck Measles Vaccine Products Offered
12.3.5 Merck Recent Development
12.4 Novartis
12.4.1 Novartis Corporation Information
12.4.2 Novartis Description and Business Overview
12.4.3 Novartis Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Novartis Measles Vaccine Products Offered
12.4.5 Novartis Recent Development
12.5 Pfizer
12.5.1 Pfizer Corporation Information
12.5.2 Pfizer Description and Business Overview
12.5.3 Pfizer Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Pfizer Measles Vaccine Products Offered
12.5.5 Pfizer Recent Development
12.6 Serum Institute of India
12.6.1 Serum Institute of India Corporation Information
12.6.2 Serum Institute of India Description and Business Overview
12.6.3 Serum Institute of India Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Serum Institute of India Measles Vaccine Products Offered
12.6.5 Serum Institute of India Recent Development
12.7 China National Biotech Group
12.7.1 China National Biotech Group Corporation Information
12.7.2 China National Biotech Group Description and Business Overview
12.7.3 China National Biotech Group Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.7.4 China National Biotech Group Measles Vaccine Products Offered
12.7.5 China National Biotech Group Recent Development
12.8 Bavarian Nordic
12.8.1 Bavarian Nordic Corporation Information
12.8.2 Bavarian Nordic Description and Business Overview
12.8.3 Bavarian Nordic Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Bavarian Nordic Measles Vaccine Products Offered
12.8.5 Bavarian Nordic Recent Development
12.9 Emergent Biosolutions
12.9.1 Emergent Biosolutions Corporation Information
12.9.2 Emergent Biosolutions Description and Business Overview
12.9.3 Emergent Biosolutions Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Emergent Biosolutions Measles Vaccine Products Offered
12.9.5 Emergent Biosolutions Recent Development
12.10 Medimmune
12.10.1 Medimmune Corporation Information
12.10.2 Medimmune Description and Business Overview
12.10.3 Medimmune Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Medimmune Measles Vaccine Products Offered
12.10.5 Medimmune Recent Development
12.11 GSK
12.11.1 GSK Corporation Information
12.11.2 GSK Description and Business Overview
12.11.3 GSK Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.11.4 GSK Measles Vaccine Products Offered
12.11.5 GSK Recent Development
12.12 CSL Limited
12.12.1 CSL Limited Corporation Information
12.12.2 CSL Limited Description and Business Overview
12.12.3 CSL Limited Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.12.4 CSL Limited Products Offered
12.12.5 CSL Limited Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Measles Vaccine Industry Trends
13.2 Measles Vaccine Market Drivers
13.3 Measles Vaccine Market Challenges
13.4 Measles Vaccine Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Measles Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Measles Vaccine Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Mumps Measles Rubella Vaccine, Live (MMR-II)
Table 3. Major Manufacturers of Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
Table 4. Global Measles Vaccine Market Size Growth Rate by Application (2021-2027) & (K MT)
Table 5. Global Measles Vaccine Market Size by Region (K MT) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Measles Vaccine Sales by Regions (2016-2021) & (K MT)
Table 7. Global Measles Vaccine Sales Market Share by Regions (2016-2021)
Table 8. Global Measles Vaccine Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Measles Vaccine Sales Forecast by Region (2022-2027) & (K MT)
Table 10. Global Measles Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Measles Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Measles Vaccine Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Measles Vaccine Sales by Manufacturers (2016-2021) (K MT)
Table 14. Global Measles Vaccine Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Measles Vaccine Manufacturers by Revenue (US$ Million) in 2020
Table 16. Measles Vaccine Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Measles Vaccine Revenue Share by Manufacturers (2016-2021)
Table 18. Global Measles Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Measles Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Measles Vaccine as of 2020)
Table 20. Key Manufacturers Measles Vaccine Price (2016-2021) (USD/MT)
Table 21. Measles Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Measles Vaccine Product Type
Table 23. Date of International Manufacturers Enter into Measles Vaccine Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Measles Vaccine Sales by Type (2016-2021) (K MT)
Table 26. Global Measles Vaccine Sales Share by Type (2016-2021)
Table 27. Global Measles Vaccine Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Measles Vaccine Revenue Share by Type (2016-2021)
Table 29. Measles Vaccine Average Selling Price (ASP) by Type (2016-2021) & (USD/MT)
Table 30. Global Measles Vaccine Sales Forecast by Type (2022-2027) & (K MT)
Table 31. Global Measles Vaccine Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Measles Vaccine Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Measles Vaccine Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Measles Vaccine Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/MT)
Table 35. Global Measles Vaccine Sales by Application (2016-2021) (K MT)
Table 36. Global Measles Vaccine Sales Share by Application (2016-2021)
Table 37. Global Measles Vaccine Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Measles Vaccine Revenue Share by Application (2016-2021)
Table 39. Measles Vaccine Average Selling Price (ASP) by Application (2016-2021) & (USD/MT)
Table 40. Global Measles Vaccine Sales Forecast by Application (2022-2027) & (K MT)
Table 41. Global Measles Vaccine Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Measles Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Measles Vaccine Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Measles Vaccine Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/MT)
Table 45. Japan Measles Vaccine Sales (K MT) of Key Companies (2016-2021)
Table 46. Japan Measles Vaccine Sales Share by Company (2016-2021)
Table 47. Japan Measles Vaccine Revenue (US$ Million) by Company (2016-2021)
Table 48. Japan Measles Vaccine Revenue Share by Company (2016-2021)
Table 49. Japan Measles Vaccine Sales (K MT) by Type (2016-2021)
Table 50. Japan Measles Vaccine Sales Share by Type (2016-2021)
Table 51. Japan Measles Vaccine Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. Japan Measles Vaccine Price (USD/MT) by Type (2016-2021)
Table 53. Japan Measles Vaccine Sales (K MT) by Type (2022-2027)
Table 54. Japan Measles Vaccine Sales Share by Type (2022-2027)
Table 55. Japan Measles Vaccine Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. Japan Measles Vaccine Revenue Share by Type (2022-2027)
Table 57. Japan Measles Vaccine Price (USD/MT) by Type (2022-2027)
Table 58. Japan Measles Vaccine Sales (K MT) by Application (2016-2021)
Table 59. Japan Measles Vaccine Sales Share by Application (2016-2021)
Table 60. Japan Measles Vaccine Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. Japan Measles Vaccine Price (USD/MT) by Application (2016-2021)
Table 62. Japan Measles Vaccine Sales (K MT) by Application (2022-2027)
Table 63. Japan Measles Vaccine Sales Share by Application (2022-2027)
Table 64. Japan Measles Vaccine Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. Japan Measles Vaccine Revenue Share by Application (2022-2027)
Table 66. Japan Measles Vaccine Price (USD/MT) by Application (2022-2027)
Table 67. North America Measles Vaccine Sales by Country (2016-2021) & (K MT)
Table 68. North America Measles Vaccine Sales Market Share by Country (2016-2021)
Table 69. North America Measles Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Measles Vaccine Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Measles Vaccine Sales by Region (2016-2021) & (K MT)
Table 72. Asia Pacific Measles Vaccine Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Measles Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Measles Vaccine Revenue Market Share by Region (2016-2021)
Table 75. Europe Measles Vaccine Sales by Country (2016-2021) & (K MT)
Table 76. Europe Measles Vaccine Sales Market Share by Country (2016-2021)
Table 77. Europe Measles Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Measles Vaccine Revenue Market Share by Country (2016-2021)
Table 79. Latin America Measles Vaccine Sales by Country (2016-2021) & (K MT)
Table 80. Latin America Measles Vaccine Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Measles Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Measles Vaccine Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Measles Vaccine Sales by Country (2016-2021) & (K MT)
Table 84. Middle East and Africa Measles Vaccine Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Measles Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Measles Vaccine Revenue Market Share by Country (2016-2021)
Table 87. GSK Corporation Information
Table 88. GSK Description and Business Overview
Table 89. GSK Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 90. GSK Measles Vaccine Product
Table 91. GSK Recent Development
Table 92. Sanofi-Pasteur Corporation Information
Table 93. Sanofi-Pasteur Description and Business Overview
Table 94. Sanofi-Pasteur Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 95. Sanofi-Pasteur Product
Table 96. Sanofi-Pasteur Recent Development
Table 97. Merck Corporation Information
Table 98. Merck Description and Business Overview
Table 99. Merck Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 100. Merck Product
Table 101. Merck Recent Development
Table 102. Novartis Corporation Information
Table 103. Novartis Description and Business Overview
Table 104. Novartis Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 105. Novartis Product
Table 106. Novartis Recent Development
Table 107. Pfizer Corporation Information
Table 108. Pfizer Description and Business Overview
Table 109. Pfizer Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 110. Pfizer Product
Table 111. Pfizer Recent Development
Table 112. Serum Institute of India Corporation Information
Table 113. Serum Institute of India Description and Business Overview
Table 114. Serum Institute of India Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 115. Serum Institute of India Product
Table 116. Serum Institute of India Recent Development
Table 117. China National Biotech Group Corporation Information
Table 118. China National Biotech Group Description and Business Overview
Table 119. China National Biotech Group Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 120. China National Biotech Group Product
Table 121. China National Biotech Group Recent Development
Table 122. Bavarian Nordic Corporation Information
Table 123. Bavarian Nordic Description and Business Overview
Table 124. Bavarian Nordic Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 125. Bavarian Nordic Product
Table 126. Bavarian Nordic Recent Development
Table 127. Emergent Biosolutions Corporation Information
Table 128. Emergent Biosolutions Description and Business Overview
Table 129. Emergent Biosolutions Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 130. Emergent Biosolutions Product
Table 131. Emergent Biosolutions Recent Development
Table 132. Medimmune Corporation Information
Table 133. Medimmune Description and Business Overview
Table 134. Medimmune Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 135. Medimmune Product
Table 136. Medimmune Recent Development
Table 137. Johnson & Johnson Corporation Information
Table 138. Johnson & Johnson Description and Business Overview
Table 139. Johnson & Johnson Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 140. Johnson & Johnson Product
Table 141. Johnson & Johnson Recent Development
Table 142. CSL Limited Corporation Information
Table 143. CSL Limited Description and Business Overview
Table 144. CSL Limited Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 145. CSL Limited Product
Table 146. CSL Limited Recent Development
Table 147. Measles Vaccine Market Trends
Table 148. Measles Vaccine Market Drivers
Table 149. Measles Vaccine Market Challenges
Table 150. Measles Vaccine Market Restraints
Table 151. Measles Vaccine Customers List
Table 152. Measles Vaccine Distributors List
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Measles Vaccine Product Picture
Figure 2. Global Measles Vaccine Sales Market Share by Type in 2020 & 2027
Figure 3. Mumps Measles Rubella Vaccine, Live (MMR-II) Product Picture
Figure 4. Mumps Measles Rubella and Varicella Virus Vaccine (Proquad) Product Picture
Figure 5. Global Measles Vaccine Sales Market Share by Application in 2020 & 2027
Figure 6. Children
Figure 7. Adults
Figure 8. Measles Vaccine Report Years Considered
Figure 9. Global Measles Vaccine Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Measles Vaccine Market Size 2016-2027 (US$ Million)
Figure 11. Global Measles Vaccine Sales 2016-2027 (K MT)
Figure 12. Global Measles Vaccine Market Size Market Share by Region: 2021 Versus 2027
Figure 13. Global Measles Vaccine Sales Market Share by Region (2016-2021)
Figure 14. Global Measles Vaccine Sales Market Share by Region in 2020
Figure 15. Global Measles Vaccine Revenue Market Share by Region (2016-2021)
Figure 16. Global Measles Vaccine Revenue Market Share by Region in 2020
Figure 17. Global Measles Vaccine Sales Share by Manufacturer in 2020
Figure 18. The Top 10 and 5 Players Market Share by Measles Vaccine Revenue in 2020
Figure 19. Measles Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 20. Global Measles Vaccine Sales Market Share by Type (2016-2021)
Figure 21. Global Measles Vaccine Sales Market Share by Type in 2020
Figure 22. Global Measles Vaccine Revenue Market Share by Type (2016-2021)
Figure 23. Global Measles Vaccine Revenue Market Share by Type in 2020
Figure 24. Global Measles Vaccine Sales Market Share by Application (2016-2021)
Figure 25. Global Measles Vaccine Sales Market Share by Application in 2020
Figure 26. Global Measles Vaccine Revenue Market Share by Application (2016-2021)
Figure 27. Global Measles Vaccine Revenue Market Share by Application in 2020
Figure 28. Japan Measles Vaccine Sales Growth Rate 2016-2027 (K MT)
Figure 29. Japan Measles Vaccine Revenue Growth Rate 2016-2027 (US$ Million)
Figure 30. Japan Measles Vaccine Market Share in Global Market 2016-2027
Figure 31. Japan 5 and 10 Largest Measles Vaccine Players Market Share by Revenue in Measles Vaccine in 2020
Figure 32. Japan Measles Vaccine Revenue Share by Type (2016-2021)
Figure 33. Japan Measles Vaccine Revenue Growth Rate by Type in 2016 & 2020
Figure 34. Japan Measles Vaccine Revenue Share by Application (2016-2021)
Figure 35. Japan Measles Vaccine Revenue Growth Rate by Application in 2016 & 2020
Figure 36. North America Measles Vaccine Sales Growth Rate 2016-2021 (K MT)
Figure 37. North America Measles Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 38. North America Measles Vaccine Sales Market Share by Country in 2020
Figure 39. North America Measles Vaccine Revenue Market Share by Country in 2020
Figure 40. U.S. Measles Vaccine Sales Growth Rate (2016-2021) (K MT)
Figure 41. U.S. Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Canada Measles Vaccine Sales Growth Rate (2016-2021) (K MT)
Figure 43. Canada Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Europe Measles Vaccine Sales Growth Rate 2016-2021 (K MT)
Figure 45. Europe Measles Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 46. Europe Measles Vaccine Sales Market Share by Country in 2020
Figure 47. Europe Measles Vaccine Revenue Market Share by Country in 2020
Figure 48. Germany Measles Vaccine Sales Growth Rate (2016-2021) (K MT)
Figure 49. Germany Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. France Measles Vaccine Sales Growth Rate (2016-2021) (K MT)
Figure 51. France Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. U.K. Measles Vaccine Sales Growth Rate (2016-2021) (K MT)
Figure 53. U.K. Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. Italy Measles Vaccine Sales Growth Rate (2016-2021) (K MT)
Figure 55. Italy Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. Russia Measles Vaccine Sales Growth Rate (2016-2021) (K MT)
Figure 57. Russia Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Asia Pacific Measles Vaccine Sales Growth Rate 2016-2021 (K MT)
Figure 59. Asia Pacific Measles Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 60. Asia Pacific Measles Vaccine Sales Market Share by Region in 2020
Figure 61. Asia Pacific Measles Vaccine Revenue Market Share by Region in 2020
Figure 62. China Measles Vaccine Sales Growth Rate (2016-2021) (K MT)
Figure 63. China Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 64. Japan Measles Vaccine Sales Growth Rate (2016-2021) (K MT)
Figure 65. Japan Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 66. South Korea Measles Vaccine Sales Growth Rate (2016-2021) (K MT)
Figure 67. South Korea Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. India Measles Vaccine Sales Growth Rate (2016-2021) (K MT)
Figure 69. India Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. Australia Measles Vaccine Sales Growth Rate (2016-2021) (K MT)
Figure 71. Australia Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. Taiwan Measles Vaccine Sales Growth Rate (2016-2021) (K MT)
Figure 73. Taiwan Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. Indonesia Measles Vaccine Sales Growth Rate (2016-2021) (K MT)
Figure 75. Indonesia Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Thailand Measles Vaccine Sales Growth Rate (2016-2021) (K MT)
Figure 77. Thailand Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Malaysia Measles Vaccine Sales Growth Rate (2016-2021) (K MT)
Figure 79. Malaysia Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Philippines Measles Vaccine Sales Growth Rate (2016-2021) (K MT)
Figure 81. Philippines Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Vietnam Measles Vaccine Sales Growth Rate (2016-2021) (K MT)
Figure 83. Vietnam Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 84. Latin America Measles Vaccine Sales Growth Rate 2016-2021 (K MT)
Figure 85. Latin America Measles Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 86. Latin America Measles Vaccine Sales Market Share by Country in 2020
Figure 87. Latin America Measles Vaccine Revenue Market Share by Country in 2020
Figure 88. Mexico Measles Vaccine Sales Growth Rate (2016-2021) (K MT)
Figure 89. Mexico Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 90. Brazil Measles Vaccine Sales Growth Rate (2016-2021) (K MT)
Figure 91. Brazil Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 92. Argentina Measles Vaccine Sales Growth Rate (2016-2021) (K MT)
Figure 93. Argentina Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 94. Middle East and Africa Measles Vaccine Sales Growth Rate 2016-2021 (K MT)
Figure 95. Middle East and Africa Measles Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 96. Middle East and Africa Measles Vaccine Sales Market Share by Country in 2020
Figure 97. Middle East and Africa Measles Vaccine Revenue Market Share by Country in 2020
Figure 98. Turkey Measles Vaccine Sales Growth Rate (2016-2021) (K MT)
Figure 99. Turkey Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 100. Saudi Arabia Measles Vaccine Sales Growth Rate (2016-2021) (K MT)
Figure 101. Saudi Arabia Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 102. UAE Measles Vaccine Sales Growth Rate (2016-2021) (K MT)
Figure 103. UAE Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 104. Measles Vaccine Value Chain
Figure 105. Channels of Distribution
Figure 106. Distributors Profil

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......

Global Esomeprazole Magnesium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......

Global Combination Therapy Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......

Global Axitinib Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68

The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......

Global Lyme Disease Vaccine Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......

Global Transdermal Absorption Patch Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......

Global Ketoprofen Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......

Global Methyl Salicylate Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82

The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......

Global Diclofenac Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs